Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Oliver Weigert, Eva Hoster et al.|The Lancet Oncology|2015Cited by 613
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profilingJosé I. Martín‐Subero, Markus Kreuz, Marina Bibikova et al.|Blood|2008Cited by 145